Companion animal include dog, cat, fish, bird, horse, rabbit, hamster, guinea pig, and ferret. Companion animals are used for company, amusement, psychological support, extrovert display and all of the other functions that humans need to share with animals of other species. Increasing adoption of companion animals is expected to propel growth of the global companion animal drugs market over the forecast period. Furthermore, high prevalence of salmonella infection, along with increasing animal healthcare expenditure is also anticipated to assist the market growth during the forecast period.
Key features of the study:
- This report provides in-depth analysis of the Global Companion Animal Drugs market and provides market size (US$ million) and compound annual growth rate (CAGR %) for the forecast period (2020–2027), considering 2019 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategy adopted by key players
- It profiles key players in the Global Companion Animal Drugs market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
- Key companies covered as a part of this study include, Zoetis Inc., Merck & Co., Inc., Bayer AG, Eli Lily & Co., Sanofi (Merial), Ceva Santé Animal, Virbac Animal Health, and Boehringer Ingelheim GmbH
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
- The Global Companion Animal Drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the Global Companion Animal Drugs market
Detailed Segmentation:
- Global Companion Animal Drugs Market, By Product Type:
- Antibiotics
- Anti-inflammatory
- Parasiticides
- Ecto-Parasiticides
- Endo-Parasiticides
- Heart worm Products
- Behavioral Products
- Nutritional Products
- Skin care Products
- Vaccines
- Global Companion Animal Drugs Market, By Distribution Channel:
- Veterinary Hospitals
- Veterinary Clinics
- Pharmacies and Drug Stores
- Global Companion Animal Drugs Market, By Region:
- North America
- By Product Type:
- Antibiotics
- Anti-inflammatory
- Parasiticides
- Ecto-Parasiticides
- Endo-Parasiticides
- Heart worm Products
- Behavioral Products
- Nutritional Products
- Skin care Products
- Vaccines
- By Distribution Channel
- Veterinary Hospitals
- Veterinary Clinics
- Pharmacies and Drug Stores
- By Country
- Latin America
- By Product Type:
- Antibiotics
- Anti-inflammatory
- Parasiticides
- Ecto-Parasiticides
- Endo-Parasiticides
- Heart worm Products
- Behavioral Products
- Nutritional Products
- Skin care Products
- Vaccines
- By Distribution Channel
- Veterinary Hospitals
- Veterinary Clinics
- Pharmacies and Drug Stores
- By Country
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- By Product Type:
- Antibiotics
- Anti-inflammatory
- Parasiticides
- Ecto-Parasiticides
- Endo-Parasiticides
- Heart worm Products
- Behavioral Products
- Nutritional Products
- Skin care Products
- Vaccines
- By Distribution Channel
- Veterinary Hospitals
- Veterinary Clinics
- Pharmacies and Drug Stores
- By Country
- U.K.
- Germany
- France
- Spain
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- By Product Type:
- Antibiotics
- Anti-inflammatory
- Parasiticides
- Ecto-Parasiticides
- Endo-Parasiticides
- Heart worm Products
- Behavioral Products
- Nutritional Products
- Skin care Products
- Vaccines
- By Distribution Channel
- Veterinary Hospitals
- Veterinary Clinics
- Pharmacies and Drug Stores
- By Country
- China
- Japan
- India
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- By Product Type:
- Antibiotics
- Anti-inflammatory
- Parasiticides
- Ecto-Parasiticides
- Endo-Parasiticides
- Heart worm Products
- Behavioral Products
- Nutritional Products
- Skin care Products
- Vaccines
- By Distribution Channel
- Veterinary Hospitals
- Veterinary Clinics
- Pharmacies and Drug Stores
- By Country
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- By Product Type:
- Antibiotics
- Anti-inflammatory
- Parasiticides
- Ecto-Parasiticides
- Endo-Parasiticides
- Heart worm Products
- Behavioral Products
- Nutritional Products
- Skin care Products
- Vaccines
- By Distribution Channel
- Veterinary Hospitals
- Veterinary Clinics
- Pharmacies and Drug Stores
- By Country
- North Africa
- Central Africa
- South Africa
- Company Profiles
- Zoetis Inc. *
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Merck & Co., Inc.
- Bayer AG
- Eli Lily & Co.
- Sanofi (Merial)
- Ceva Santé Animal
- Virbac Animal Health
- Boehringer Ingelheim GmbH
- “*” marked represents similar segmentation in other categories in the respective section.
